ESR2 and breast cancer: ERβ suppression inhibits EMT and reduces the expression levels of MMP1, 2, 7, 9 and 14 following reduced ERK1/2 activation stimulated by EGFR/IGF-IR and JAK2/STAT5-mediated migration in breast cancer cells [54].